The role of the T-N tract in advanced stage tongue cancer.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
08 2019
Historique:
received: 10 08 2018
revised: 11 03 2019
accepted: 18 03 2019
pubmed: 4 4 2019
medline: 24 11 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

We investigated the role of the soft tissue tract between the primary tumor and the neck lymph nodes, the "T-N tract," in patients with tongue squamous cell carcinoma at an advanced stage. We performed a compartmental tongue surgery in 233 patients. Cumulative incidence of relapses and overall survival curves were compared by T-N tract involvement. Multivariate Cox proportional hazards models were used to assess the independent role of T-N tract. At 4 years of follow-up, patients with disease in the T-N tract experienced a significantly more distant recurrence (40%) than did patients without T-N tract involvement (22%; P = .02). Multivariate Cox models indicate a significant almost triple risk of distant metastases (hazard ratio [HR], 2.70; 95% CI, 1.01-7.19; P = .05) and double risk of death (HR, 2.09; 95%CI, 1.13-3.85; P = .02) in patients with "T-N tract involvement." Our data show that the T-N tract plays an important role in prognosis and survival in patients with tongue cancer.

Sections du résumé

BACKGROUND
We investigated the role of the soft tissue tract between the primary tumor and the neck lymph nodes, the "T-N tract," in patients with tongue squamous cell carcinoma at an advanced stage.
METHODS
We performed a compartmental tongue surgery in 233 patients. Cumulative incidence of relapses and overall survival curves were compared by T-N tract involvement. Multivariate Cox proportional hazards models were used to assess the independent role of T-N tract.
RESULTS
At 4 years of follow-up, patients with disease in the T-N tract experienced a significantly more distant recurrence (40%) than did patients without T-N tract involvement (22%; P = .02). Multivariate Cox models indicate a significant almost triple risk of distant metastases (hazard ratio [HR], 2.70; 95% CI, 1.01-7.19; P = .05) and double risk of death (HR, 2.09; 95%CI, 1.13-3.85; P = .02) in patients with "T-N tract involvement."
CONCLUSIONS
Our data show that the T-N tract plays an important role in prognosis and survival in patients with tongue cancer.

Identifiants

pubmed: 30942940
doi: 10.1002/hed.25761
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2756-2767

Subventions

Organisme : HPV-AHEAD
ID : FP7-HEALTH-2011-282562
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Marta Tagliabue (M)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Sara Gandini (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Fausto Maffini (F)

Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.

Valeria Navach (V)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Roberto Bruschini (R)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Gioacchino Giugliano (G)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Francesca Lombardi (F)

Division of Data Manager, European Institute of Oncology IRCCS, Milan, Italy.

Susanna Chiocca (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Elisabetta Rebecchi (E)

Department of Otolaryngology Head Neck Surgery, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Eleonora Sica (E)

Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi, Ospedale di circolo Fondazione Macchi, Varese, Italy.

Massimo Tommasino (M)

Infections and Cancer Biology Group, International Agency for Research on Cancer, Course Albert Thomas 150, Lyon, France.

Luca Calabrese (L)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Mohssen Ansarin (M)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH